Back

Impact of SGLT2i on CV mortality and SCD

13 May 2024 (13:00 - 13:30)
Organised by: Logo
Congress Presentation Part of: Guideline recommended medical therapy - implications of current publications and guidelines for daily clinical practice Ventricular Remodelling HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mauro Feola

Cardiology Department, Mondovi (Italy)

1 More presentation in this session

Presentation thumbnail
When does GDMT kick-in according to current publications?
Associate Professor P. Rainer (St Johann in Tirol, AT)

Access the full session

Session thumbnail
Guideline recommended medical therapy - implications of current publications and guidelines for daily clinical practice

The Event

Event poster

Heart Failure 2024

13 May 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease
27 August 2022
thumbnail
ESC TV Today
Episode 2: The why and how of MRAs in heart failure - Managing electrical storm
10 October 2024
thumbnail
Webinar
Early initiation of SGLT-2 inhibitors after acute decompensated heart failure
26 October 2022
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources